Furthermore, even the 75 mg/kg dose of metformin, which did not affect pyruvate tolerance, continued to lower blood glucose in the presence of exendin(9-39) (ESM Fig
However, responses can vary, and some people may experience side effects, particularly with prolonged use, high doses, or certain delivery methods
CDMO/CMO Outlook: Fill-Finish: A Capacity Crunch or Capacity Easing
Large drug makers have paid billions to resolve off-label marketing cases
What seems like a local update carries global lessons for pharma: tighter risk management, new retail dynamics, and faster label/supply chain pivots
sulphur burps are not captured as a discrete adverse event but are a recognised patient complaint across the GLP-1 agonist class